Adrenocorticotropin-secreting pituitary tumor represents about 10 % of pituitary adenomas and at the time of diagnosis most of them are microadenomas. Transsphenoidal surgery is the first-line treatment of Cushing’s disease and accurate localization of the tumor within the gland is essential for selectively removing the lesion and preserving normal pituitary function. Magnetic resonance imaging is the best imaging modality for the detection of pituitary tumors, but adrenocorticotropin-secreting pituitary microadenomas are not correctly identified in 30–50 % of cases, because of their size, location, and enhancing characteristics. Several recent studies were performed with the purpose of better localizing the adrenocorticotropin-secreting microadenomas through the use in magnetic resonance imaging of specific sequences, reduced contrast medium dose and high-field technology. Therefore, an improved imaging technique for pituitary disease is mandatory in the suspect of Cushing’s disease. The aims of this paper are to present an overview of pituitary magnetic resonance imaging in the diagnosis of Cushing’s disease and to provide a magnetic resonance imaging protocol to be followed in case of suspicion adrenocorticotropin-secreting pituitary adenoma.

Pituitary magnetic resonance imaging in Cushing’s disease / G. Vitale, F. Tortora, R. Baldelli, F. Cocchiara, R.M. Paragliola, E. Sbardella, C. Simeoli, F. Caranci, R. Pivonello, A. Colao. - In: ENDOCRINE. - ISSN 1355-008X. - 55:3(2017 Mar), pp. 691-696. [10.1007/s12020-016-1038-y]

Pituitary magnetic resonance imaging in Cushing’s disease

G. Vitale
Primo
;
2017

Abstract

Adrenocorticotropin-secreting pituitary tumor represents about 10 % of pituitary adenomas and at the time of diagnosis most of them are microadenomas. Transsphenoidal surgery is the first-line treatment of Cushing’s disease and accurate localization of the tumor within the gland is essential for selectively removing the lesion and preserving normal pituitary function. Magnetic resonance imaging is the best imaging modality for the detection of pituitary tumors, but adrenocorticotropin-secreting pituitary microadenomas are not correctly identified in 30–50 % of cases, because of their size, location, and enhancing characteristics. Several recent studies were performed with the purpose of better localizing the adrenocorticotropin-secreting microadenomas through the use in magnetic resonance imaging of specific sequences, reduced contrast medium dose and high-field technology. Therefore, an improved imaging technique for pituitary disease is mandatory in the suspect of Cushing’s disease. The aims of this paper are to present an overview of pituitary magnetic resonance imaging in the diagnosis of Cushing’s disease and to provide a magnetic resonance imaging protocol to be followed in case of suspicion adrenocorticotropin-secreting pituitary adenoma.
Cushing’s disease; imaging; MRI; pituitary microadenoma; endocrinology, diabetes and metabolism; endocrinology
Settore MED/13 - Endocrinologia
mar-2017
Article (author)
File in questo prodotto:
File Dimensione Formato  
ENDOCRINE 2017 Pituitary MRI.pdf

accesso riservato

Tipologia: Publisher's version/PDF
Dimensione 331.93 kB
Formato Adobe PDF
331.93 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/449098
Citazioni
  • ???jsp.display-item.citation.pmc??? 16
  • Scopus 56
  • ???jsp.display-item.citation.isi??? 46
social impact